e-learning
resources
Vienna 2009
Monday, 14.09.2009
Diagnosis of pleural effusions and rare tumours experience
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The use of pleural fluid C-reactive protein level, as a diagnostic marker for pleural effusions
P. Kapisyzi, D. Argjiri, G. Byrazeri, J. Beli, Y. Vakeflliu, R. Kore, E. Shehu, A. Aliko, A. Mitre (Tirana, Tirane, Albania)
Source:
Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Session:
Diagnosis of pleural effusions and rare tumours experience
Session type:
E-Communication Session
Number:
1921
Disease area:
Respiratory infections, Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Kapisyzi, D. Argjiri, G. Byrazeri, J. Beli, Y. Vakeflliu, R. Kore, E. Shehu, A. Aliko, A. Mitre (Tirana, Tirane, Albania). The use of pleural fluid C-reactive protein level, as a diagnostic marker for pleural effusions. Eur Respir J 2009; 34: Suppl. 53, 1921
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
N3 hilar sampling decision in the staging of mediastinal lung cancer
Asbestosis
Management of solitary fibrous tumours of the pleura: a systematic review and meta-analysis
Related content which might interest you:
The diagnostic value of pleural fluid C-reactive protein level in pleural effusions
Source: Eur Respir J 2002; 20: Suppl. 38, 356s
Year: 2002
Usefulness of pleural fluid C-reactive protein in differentiation of pleural effusions
Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges
Year: 2010
Usefulness of pleural fluid C-reactive protein in differentiation of pleural effusions
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009
Correlation between pleural fluid and serum C-reactive protein in patients with pleural effusion due to different etiologies
Source: Virtual Congress 2020 – Interesting clinical problems for the respiratory physician
Year: 2020
Pleural fluid procalcitonin levels in identifying pleural effusions due to infection
Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections
Year: 2009
Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019
The diagnostic role of pleural fluid and serum Pentraxin-3 levels in the determination of the etiology of pleural effusion
Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases
Year: 2017
Serum C-reactive protein levels predict the need for surgical intervention in patients with empyema/complicated parapneumonic pleural effusions
Source: International Congress 2019 – Pleural infection and complicated pneumonia
Year: 2019
Diagnostic value of C-reactive protein in exudative pleural effusions
Source: International Congress 2019 – Clinical problems
Year: 2019
Procalcitonin and CRP levels in pleural effusions
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009
Biomarkers of infection for the differential diagnosis of pleural effusions
Source: Eur Respir J 2009; 34: 1383-1389
Year: 2009
Pleural fluid leptin level for the differential diagnosis of pleural effusion
Source: Eur Respir J 2006; 28: Suppl. 50, 343s
Year: 2006
Diagnostic value of procalcitonin and C-reactive protein in the differentiation among bening and malignant pleural effusion
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009
Pleural fluid C-reactive protein concentration in discriminating uncomplicated from complicated parapneumonic pleural effusion
Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections
Year: 2012
C-reactive protein in differentiation between tuberculous and malignant pleural effusions
Source: Annual Congress 2011 - Clinical challenges in tuberculosis
Year: 2011
Pleural fluid, serum β-HCG levels and pleural fluid/serum β-HCG ratio for the discrimination of malignant and benign pleural effusions
Source: Eur Respir J 2003; 22: Suppl. 45, 60s
Year: 2003
The implication of C-reactive protein in differentiation of various pleural effusion etiologies
Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention
Year: 2008
Value of pleural fluid and serum NT-ProBNP levels in differentiation of transudative and exudative pleural effusions
Source: Annual Congress 2010 - Novel approach in diagnosis and treatment of pleural effusions
Year: 2010
The investigation of diagnostic value of serum reactive protein (CRP) in patients with pleural effusion
Source: Eur Respir J 2006; 28: Suppl. 50, 374s
Year: 2006
Role of C-reactive protein in distinguishing between transudative and exudative pleural effusion
Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept